Pharmaids Pharmaceuticals Live BSE/NSE | Pharmaids Pharmaceuticals Fundamenta data | Pharmaids Pharmaceuticals Balance sheet | Pharmaids Pharmaceuticals Quarterly Results | Pharmaids Pharmaceuticals Profit & Loss | Pharmaids Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9.49
77.76
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9.46
N/A
1.12

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

0.68
0.68
0.68

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.05
8.46
-9.81

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 1 -100% 0 0 0
Expenses 0 0 -86% 0 0 -50% 0 0 -60% 0 0 -33%
EBITDA 0 0 - 0 0 - 0 0 - 0 0 -
EBIDTM 0% 0% 0% 0% 0% 11% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 -50% 0 0 0
PBT 0 0 - 0 0 - 0 0 - 0 0 -
Tax 0 0 0 0 0 - 0 0 0 0 0 0
PAT 0 0 - 0 0 - 0 0 - 0 0 -
PATM 0% 0% 3% 0% 0% 8% 0% 0%
EPS 0.00 -0.07 - 0.36 -0.05 - -0.19 0.04 - -0.06 -0.09 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 0 0 1 0 1 2 2 1 1 1 1 Net Sales Growth -100% -100% 24% -62% -29% -3% 23% 11% 2% 59% Cost Of Goods Sold 499 0 0 0 1 1 1 1 1 1 1 Gross Profit -499 0 0 0 1 1 1 0 0 0 0 GP Margin 0% 0 36% -11% 44% 32% 40% 30% 33% 35% 17% Total Expenditure 0 0 1 1 2 2 2 2 1 1 1 Power & Fuel Cost - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0 0% 0% 1% 1% 1% 0% 1% 1% 0% Employee Cost - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0 9% 13% 14% 12% 10% 7% 7% 6% 4% Manufacturing Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0 0% 2% 7% 5% 3% 4% 5% 2% 1% General & Admin Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0 27% 47% 16% 14% 12% 12% 9% 9% 9% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0 16% 13% 9% 9% 9% 13% 6% 7% 8% Miscellaneous Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0 2% 0% 27% 11% 9% 25% 0% 1% 0% EBITDA 0 0 0 0 0 0 0 0 0 0 0 EBITDA Margin 0% 0 -18% -87% -29% -21% -5% -30% 6% 11% -6% Other Income 0 0 0 0 0 0 0 0 0 0 0 Interest 0 0 0 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0 0 0 0 PBT 0 0 0 0 0 0 0 0 0 0 0 Tax 0 0 0 0 0 0 0 0 0 0 0 Tax Rate 141% 108% -21% -5% -38% 7% 36% 3% -25% -50% 8% PAT 0 0 0 0 0 0 0 0 0 0 0 PAT before Minority Interest 0 0 0 0 0 0 0 0 0 0 0 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 0% 0 -32% -87% 9% -24% -4% -25% 4% 3% -15% PAT Growth 167% 117% 54% -455% 128% -471% 80% -800% 25% 133% EPS 0.12 0.03 -0.17 -0.38 0.11 -0.39 -0.07 -0.34 0.05 0.04 -0.12

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

Net Sales Growth

-100%

24%

-62%

-29%

-3%

23%

11%

59%

Cost Of Goods Sold

499

Gross Profit

-499

GP Margin

36%

-11%

44%

32%

40%

30%

33%

35%

17%

Total Expenditure

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

13%

14%

12%

10%

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

27%

47%

16%

14%

12%

Selling & Distn. Exp.

% Of Sales

16%

13%

Miscellaneous Exp.

% Of Sales

27%

11%

25%

EBITDA

EBITDA Margin

-18%

-87%

-29%

-21%

-5%

-30%

11%

-6%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

141%

108%

-21%

-5%

-38%

36%

-25%

-50%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

-32%

-87%

-24%

-4%

-25%

-15%

PAT Growth

167%

117%

54%

-455%

128%

-471%

80%

-800%

25%

133%

EPS

0.12

0.03

-0.17

-0.38

0.11

-0.39

-0.07

-0.34

0.05

0.04

-0.12

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 8 8 1 1 1 2 2 2 2 2 Share Capital 10 10 3 3 3 3 3 3 3 3 Total Reserves -2 -2 -2 -2 -2 -2 -2 -1 -1 -1 Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 0 0 0 0 1 1 1 1 1 1 Trade Payables 0 0 0 0 0 0 1 0 0 0 Other Current Liabilities 0 0 0 0 0 0 0 0 0 0 Short Term Borrowings 0 0 0 0 0 0 0 0 0 1 Short Term Provisions 0 0 0 0 0 0 0 0 0 0 Total Liabilities 8 9 1 2 2 3 3 3 3 3 Net Block 0 0 0 0 0 0 1 1 1 1 Gross Block 1 0 0 0 2 2 2 2 2 2 Accumulated Depreciation 0 0 0 0 2 2 1 1 1 1 Non Current Assets 7 4 1 0 1 1 1 1 1 2 Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 Non Current Investment 0 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 6 4 1 0 0 0 1 1 1 1 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 1 4 1 2 2 2 2 2 2 2 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 0 0 0 0 0 0 0 0 0 0 Sundry Debtors 1 1 1 1 1 1 1 2 1 1 Cash & Bank 0 0 0 1 0 0 0 0 0 0 Other Current Assets 0 0 0 0 0 0 0 0 0 0 Short Term Loans & Adv. 0 3 0 0 0 0 0 0 0 0 Net Current Assets 1 4 1 1 1 1 1 1 1 1 Total Assets 8 9 1 2 2 3 3 3 3 3

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

Share Capital

Total Reserves

-2

-1

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -1 0 0 0 0 0 0 0 0 0 PBT 0 0 0 0 0 0 0 0 0 0 Adjustment 0 0 0 0 0 0 0 0 0 0 Changes in Working Capital 0 0 0 0 0 0 0 0 0 0 Cash after chg. in Working capital -1 0 0 0 0 0 0 0 0 0 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid 0 0 0 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity 1 0 0 0 0 0 0 0 0 0 Net Fixed Assets 0 -1 0 2 0 0 0 0 0 0 Net Investments 0 0 0 0 0 0 0 0 0 0 Others 1 1 0 -2 0 0 0 0 0 0 Cash from Financing Activity 0 0 0 0 0 0 0 0 -1 0 Net Cash Inflow / Outflow 0 0 0 0 0 0 0 0 0 0 Opening Cash & Equivalents 0 0 1 0 0 0 0 0 0 0 Closing Cash & Equivalent 0 0 0 1 0 0 0 0 0 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-1

PBT

Adjustment

Changes in Working Capital

Cash after chg. in Working capital

-1

Interest Paid

Tax Paid

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

Net Fixed Assets

-1

Net Investments

Others

-2

Cash from Financing Activity

-1

Net Cash Inflow / Outflow

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 8 8 3 4 4 5 5 6 6 6 ROA 0% -4% -23% 5% -16% -2% -12% 2% 1% -3% ROE 0% -4% -31% 8% -26% -4% -18% 2% 2% -6% ROCE -4% -3% -30% 8% -21% -5% -15% 2% 2% -4% Fixed Asset Turnover 0.00 2.40 199.51 0.00 0.81 0.85 0.68 0.62 0.63 0.40 Receivable days 0 457 530 283 237 250 368 431 398 586 Inventory Days 0 0 0 81 63 60 66 58 48 102 Payable days 308 112 270 149 90 105 112 96 76 72 Cash Conversion Cycle -308 345 260 214 209 205 322 393 370 615 Total Debt/Equity 0.00 0.00 0.00 0.00 0.36 0.17 0.20 0.20 0.25 0.48 Interest Cover -446 -215 -261 3 -14 -68 -44 6 2 -159

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

-4%

-23%

-16%

-2%

-12%

-3%

ROE

-4%

-31%

-26%

-4%

-18%

-6%

ROCE

-4%

-3%

-30%

-21%

-5%

-15%

-4%

Fixed Asset Turnover

0.00

2.40

199.51

0.00

0.81

0.85

0.68

0.62

0.63

0.40

Receivable days

457

530

283

237

250

368

431

398

586

Inventory Days

102

Payable days

308

112

270

149

105

112

Cash Conversion Cycle

-308

345

260

214

209

205

322

393

370

615

Total Debt/Equity

0.00

0.36

0.17

0.20

0.25

0.48

Interest Cover

-446

-215

-261

-14

-68

-44

-159

Pharmaids Pharmaceuticals Ltd.

Trading

BSE: 524572 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Pharmaids Pharmaceuticals Ltd.

Trading

BSE: 524572 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update